AXT Inc. (AXTI) Stock Price Down 3.6%
AXT Inc. (NASDAQ:AXTI) fell 3.6% during trading on Friday . The company traded as low as $4.32 and last traded at $4.33, with a volume of 118,212 shares. The stock had previously closed at $4.49.
A number of research firms recently commented on AXTI. B. Riley reaffirmed a “buy” rating and set a $4.80 target price on shares of AXT in a report on Tuesday, August 2nd. Zacks Investment Research raised AXT from a “hold” rating to a “strong-buy” rating and set a $3.50 target price for the company in a report on Wednesday, May 4th. Craig Hallum raised AXT from a “hold” rating to a “buy” rating in a report on Tuesday, May 3rd. Finally, TheStreet raised AXT from a “hold” rating to a “buy” rating in a report on Wednesday, May 25th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $4.93.
The firm’s 50-day moving average is $3.76 and its 200 day moving average is $3.14. The company’s market capitalization is $142.26 million.
AXT (NASDAQ:AXTI) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.02. The company had revenue of $20.50 million for the quarter, compared to analysts’ expectations of $19.97 million. The business’s revenue for the quarter was down 2.4% on a year-over-year basis. On average, equities analysts predict that AXT Inc. will post $0.13 EPS for the current year.
AXT, Inc (AXT) is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. The Company is engaged in the design, development, manufacture and distribution of compound semiconductor substrates and sale of materials.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.